LEPTON ANNOUNCED THAT IT COMPLETED THE FILING FOR AN ADDITIONAL PATENT APPLICATION WHICH DESCRIBES AND CLAIMS EXTENDING THE USAGE OF ITS CASTLING BREAKTHROUGH TECHNOLOGIES FOR ENHANCING THE THERAPEUTIC EFFICACY OF IMMUNE CELLS DERIVED FROM iPSC CELLS
The patent application, U.S. Provisional Patent Application No. 63/520,949, is entitled METHODS FOR ENHANCING THERAPEUTIC EFFICACY OF ISOLATED CELLS FOR CELL THERAPY was filed on filed August 22, 2023.
This disclosure relates to methods for enhancing the therapeutic efficacy of isolated cells derived from stem cells such as but not limited to induced pluripotent stem cells (iPSC) and embryonic stem cells for use in cell therapies such as but not limited to adoptive cell transfer therapies.
